The National Medicines Regulatory Authority (NMRA) wishes to inform all applicants that, in accordance with the decision of the NMRA Management Meeting held on 05 May 2026, the following fee policy shall apply with effect from 05 May 2026:

• The USD 90 processing fee paid at the time of submitting a pharmacy application shall remain valid for a period of three (03)years from the date of payment.
• During this three-year validity period,applicants requesting amendments to an approved pharmacy application or licence shall only be required to pay the applicable amendment fee prescribed in the relevant Gazette Extraordinary.
• No additional USD 90 processing fee shall be charged for amendment applications submitted within the above three-year validity period.
• Any amendment application submitted on or after 05 May 2026 that was charged an additional USD 90 processing fee, despite the original processing fee remaining valid, will be reviewed by the Pharmacy Regulatory Division. Any necessary corrective action will be taken in accordance with the decision of the Authority.

 This decision has been made to ensure the uniform implementation of the approved fee structure and the consistent application of the provisions of the applicable Gazette.

 Applicants requiring further information may contact the Pharmacy Regulatory Division through the official NMRA communication channels.

 Click Here : Web Notice

‍

This notice is effective from 05 May 2026.

Pharmacy Regulatory Division

National Medicines Regulatory Authority (NMRA)

Date of Issue: 08.07.2026

‍